Biblio

Author Title [ Type(Asc)] Year
Filters: Author is Sweiss, Karen  [Clear All Filters]
Journal Article
Saraf SL, Oh AL, Patel PR, Jalundhwala Y, Sweiss K, Koshy M, Campbell-Lee S, Gowhari M, Hassan J, Peace D, et al. Non-Myeloablative Stem Cell Transplant with Alemtuzumab/Low Dose Irradiation to Cure and Improve the Quality of Life of Adults with Sickle Cell Disease. Biol Blood Marrow Transplant. 2015.
Christian S, Arain S, Patel P, Khan I, Calip GS, Agrawal V, Sweiss K, Griffin S, Cahill K, Konig H, et al. A Multi-institutional Comparison of Mitoxantrone, Etoposide, and Cytarabine (MEC) versus High-Dose Cytarabine and Mitoxantrone (Ara-C Couplets) Therapy for Patients with Relapsed or Refractory Acute Myeloid Leukemia. Am J Hematol. 2020.
Saraf SL, Ghimire K, Patel P, Sweiss K, Gowhari M, Molokie RE, Gordeuk VR, Rondelli D. Improved health care utilization and costs in transplanted versus non-transplanted adults with sickle cell disease. PLoS One. 2020;15(2):e0229710.
Maahs L, Patel P, Koshy M, Sweiss K, Chen Z, Xu Z, Aydogan B, Rondelli D. High dose total marrow irradiation (TMI) does not increase long-term toxicity of myeloablative fludarabine/busulfan (FluBu4) conditioning regimen in allogeneic hematopoietic stem cell transplantation (HSCT). Eur J Haematol. 2024.
Poudyal BSharma, Tuladhar S, Neupane S, Sapkota S, Pandit S, Shrestha PRaj, Poudel B, Bajaracharya M, Sweiss K, Patel P, et al. Hematopoietic Stem Cell Transplantation in Nepal: international partnership, implementation steps and clinical outcomes. Transplant Cell Ther. 2022.
Lin Y, Park Y, Khanal A, Campbell-Lee S, Liu L, Chen Z, Patel P, Vidanovic V, Sweiss K, Irene G, et al. A Comparison of Four Leukapheresis Methods to Harvest an Optimal Dose of CD34+ Cells: A Single Center Experience. Eur J Haematol. 2022.
Han J, Holden CC, Ahluwalia AY, Molokie RE, Gowhari M, Sweiss K, Patel PR, Gordeuk VR, Rondelli D, Saraf SL. Chronic opioid use can be reduced or discontinued after haematopoietic stem cell transplantation for sickle cell disease. Br J Haematol. 2020.